431 related articles for article (PubMed ID: 29663448)
21. [Detection of parvovirus B19 markers in blood samples of donors].
Filatova EV; Zubkova NV; Novikova NA; Golitsina LN; Kuznetsov KV
Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):67-70. PubMed ID: 21061580
[TBL] [Abstract][Full Text] [Related]
22. [Parvovirus B19 among blood donors from three hospitals in Santiago, Chile].
Lévican J; Torres M; Gaggero N; Corvalán R; Gaggero A
Rev Med Chil; 2011 Feb; 139(2):143-9. PubMed ID: 21773649
[TBL] [Abstract][Full Text] [Related]
23. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
[TBL] [Abstract][Full Text] [Related]
24. Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.
Slavov SN; Gonçalves de Noronha LA; Gonzaga FAC; Pimentel BMS; Kashima S; Haddad R
J Med Microbiol; 2019 Apr; 68(4):622-626. PubMed ID: 30843782
[TBL] [Abstract][Full Text] [Related]
25. The human parvovirus B19/human immunodeficiency virus co-infection in healthy eligible voluntary blood donors at the Blood Transfusion National Center in Kinshasa.
Alain CB; Antoine LK; Bizette BN; Dahlia P; Dophie TB; Jérémie MM; Donatien KN; Steve AM
Pan Afr Med J; 2020; 35():69. PubMed ID: 32523647
[TBL] [Abstract][Full Text] [Related]
26. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients.
Siritantikorn S; Kaewrawang S; Siritanaratkul N; Theamboonlers A; Poovorawan Y; Kantakamalakul W; Wasi C
Asian Pac J Allergy Immunol; 2007; 25(2-3):169-74. PubMed ID: 18035805
[TBL] [Abstract][Full Text] [Related]
27. The seroprevalence of parvovirus B19 antibody in blood donors at the National Blood Transfusion Center in Kinshasa.
Chabo Byaene A; Kabututu ZP; Abou Rayia DM; El-Sokkary MMA
J Med Virol; 2020 Mar; 92(3):288-294. PubMed ID: 31646654
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
29. Parvovirus B19 seroprevalence in Turkish blood donors.
Göral Ş; Yenicesu İ; Bozdayı G; Duyan Çamurdan A; Altay Koçak A
Turk J Med Sci; 2018 Oct; 48(5):956-960. PubMed ID: 30384560
[TBL] [Abstract][Full Text] [Related]
30. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
31. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.
Thomas I; Di Giambattista M; Gérard C; Mathys E; Hougardy V; Latour B; Branckaert T; Laub R
Vox Sang; 2003 May; 84(4):300-7. PubMed ID: 12757504
[TBL] [Abstract][Full Text] [Related]
33. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
34. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
35. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
36. Molecular Study of Parvovirus B19 Infection in Children with Acute Myeloid Leukemia.
Tharwat Abou El-Khier N; Darwish A; El Sayed Zaki M
Asian Pac J Cancer Prev; 2018 Feb; 19(2):337-342. PubMed ID: 29479965
[TBL] [Abstract][Full Text] [Related]
37. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009.
Kooistra K; Mesman HJ; de Waal M; Koppelman MH; Zaaijer HL
Vox Sang; 2011 Apr; 100(3):261-6. PubMed ID: 20946549
[TBL] [Abstract][Full Text] [Related]
39. Serological and Molecular Biological Studies of Parvovirus B19, Coxsackie B Viruses, and Adenoviruses as Potential Cardiotropic Viruses in Bulgaria.
Ivanova SK; Angelova SG; Stoyanova AP; Georgieva IL; Nikolaeva-Glomb LK; Mihneva ZG; Korsun NS
Folia Med (Plovdiv); 2016 Dec; 58(4):250-256. PubMed ID: 28068282
[TBL] [Abstract][Full Text] [Related]
40. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
